The GSB-2022 Scientific Committee is inviting the submission of scientific abstracts for proffered paper and poster sessions.

Authors are asked to submit abstracts under one of the following categories, but not limited:

 

New Drug Targets	Fusion Protein Drugs
Next Generation Peptides, Peptidomimetics	ADCs
Biospecific Antibodies	siRNA, micro-RNA
CAR-Ts	TCRs
Stem Cell Therapy	New Gene Therapy
PROTACs Degraders	COVID-19 Diagnostics, Therapies and Vaccines
AI-Driven Biopharm Discovery	Gene and Genome Editing
Next Generation Biopharm Screening and Design	New Discovery Chemistry
Innovative Bioprocessing Techniques	Bio-separation/Purification
New Bio-drug Delivery Systems	New Biosimilars

 

Abstracts must be in English and contain a maximum of 2800 characters with space in Microsoft Word. A data table may be included where required, but will count as 600 characters against the 2800 characters total. A maximum of 1 image file may also be included, but each image will count as 600 characters against the 2800 characters total. All abstracts accepted by the Scientific Committee will be published in the conference proceeding. The Scientific Committee will review all submitted abstracts, and will determine if an abstract is to be presented orally, by poster, or by publication only.

Abstracts failing to meet minimum standards or are not relevant to this conference will be declined. Authors may submit multiple abstracts, but usually an individual will not be offered more than one oral presentation.